908 Devices Reports Q3 2026 Revenue Growth of 35% Driven by FTIR Portfolio
908 Devices (MASS) reported strong third-quarter 2026 financial results, achieving $19.0 million in revenue, a 35% increase year-over-year. This growth was primarily fueled by the company's FTIR product portfolio and the integration of NIRLab revenue. The company also saw significant international expansion, with international revenue doubling to represent 40% of total quarterly sales. Despite the top-line strength, the company reported a net loss from continuing operations of $4.6 million, though this was a substantial improvement from the $14.9 million loss in the prior year period. While adjusted gross margins saw a slight 40-basis-point decline due to a higher mix of lower-margin international sales, management raised its full-year 2026 revenue guidance to a range of $68.5 million to $70.0 million.
Topics: international expansion net loss reduction product shipments revenue growth